Sun Pharma says U.S. FDA to lift ban on Mohali plant exports

India's largest drugmaker Sun Pharmaceutical Industries said U.S. regulators plan to lift a ban on its Mohali plant in northern India , paving the way for a resumption of exports to the company’s biggest market after four years. The move would come as a boost to Sun, whose U.S. growth has been hit over the past year…Read more Sun Pharma says U.S. FDA to lift ban on Mohali plant exports